PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY END-USER PART 07: MARKET SEGMENTATION BY TYPE • Market segmentation by type • Comparison by type • Pap smear test - Market size and forecast 2018-2023 • HPV testing - Market size and forecast 2018-2023 • Market opportunity by type PART 08: CUSTOMER LANDSCAPE PART 09: MARKET SEGMENTATION BY TECHNOLOGY PART 10: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • Americas - Market size and forecast 2018-2023 • EMEA - Market size and forecast 2018-2023 • APAC - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 11: MARKET SEGMENTATION BY METHOD PART 12: DECISION FRAMEWORK PART 13: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 14: MARKET TRENDS PART 15: VENDOR LANDSCAPE • Overview • Landscape disruption PART 16: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abbott Laboratories • BD • F. Hoffmann-La Roche • Hologic • QIAGEN PART 17: APPENDIX Research methodology List of abbreviations PART 18: EXPLORE TECHNAVIO Exhibit 01: Global molecular diagnostics market Exhibit 02: Segments of global molecular diagnostics market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Global market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: End-user – Market share 2018-2023 (%) Exhibit 18: Type - Market share 2018-2023 (%) Exhibit 19: Comparison by type Exhibit 20: Pap smear test - Market size and forecast 2018-2023 ($ millions) Exhibit 21: Pap smear test - Year-over-year growth 2019-2023 (%) Exhibit 22: HPV testing - Market size and forecast 2018-2023 ($ millions) Exhibit 23: HPV testing - Year-over-year growth 2019-2023 (%) Exhibit 24: Market opportunity by type Exhibit 25: Customer landscape Exhibit 26: Market share by geography 2018-2023 (%) Exhibit 27: Geographic comparison Exhibit 28: Americas - Market size and forecast 2018-2023 ($ millions) Exhibit 29: Americas - Year-over-year growth 2019-2023 (%) Exhibit 30: EMEA - Market size and forecast 2018-2023 ($ millions) Exhibit 31: EMEA - Year-over-year growth 2019-2023 (%) Exhibit 32: APAC - Market size and forecast 2018-2023 ($ millions) Exhibit 33: APAC - Year-over-year growth 2019-2023 (%) Exhibit 34: Key leading countries Exhibit 35: Market opportunity Exhibit 36: Method- Market share 2018-2023 (%) Exhibit 37: Impact of drivers and challenges Exhibit 38: Growing percentage of elderly women population 2010-2016 Exhibit 39: Vendor landscape Exhibit 40: Landscape disruption Exhibit 41: Vendors covered Exhibit 42: Vendor classification Exhibit 43: Market positioning of vendors Exhibit 44: Abbott Laboratories - Vendor overview Exhibit 45: Abbott Laboratories - Business segments Exhibit 46: Abbott Laboratories - Organizational developments Exhibit 47: Abbott – Geographic focus Exhibit 48: Abbott Laboratories - Segment focus Exhibit 49: Abbott Laboratories - Key offerings Exhibit 50: BD - Vendor overview Exhibit 51: BD - Business segments Exhibit 52: BD - Organizational developments Exhibit 53: BD – Geographic focus Exhibit 54: BD - Segment focus Exhibit 55: BD - Key offerings Exhibit 56: F. Hoffmann-La Roche - Vendor overview Exhibit 57: F. Hoffmann-La Roche - Business segments Exhibit 58: F. Hoffmann-La Roche - Organizational developments Exhibit 59: F. Hoffmann-La Roche – Geographic focus Exhibit 60: F. Hoffmann-La Roche - Segment focus Exhibit 61: F. Hoffmann-La Roche - Key offerings Exhibit 62: Hologic - Vendor overview Exhibit 63: Hologic - Business segments Exhibit 64: Hologic - Organizational developments Exhibit 65: Hologic – Geographic focus Exhibit 66: Hologic - Segment focus Exhibit 67: Hologic - Key offerings Exhibit 68: QIAGEN - Vendor overview Exhibit 69: QIAGEN - Business segments Exhibit 70: QIAGEN - Organizational developments Exhibit 71: QIAGEN – Geographic focus Exhibit 72: QIAGEN - Segment focus Exhibit 73: QIAGEN - Key offerings Exhibit 74: Validation techniques employed for market sizing

Abbott Laboratories BD F. Hoffmann-La Roche Hologic QIAGEN